But the anecdotal stories reported in The Cut and on Reddit are enough to make me hesitate
At the same time, the FDA sent warning letters to dozens of specific companies for making false or misleading claims about their compounded GLP-1 drugs
Nausea and loss of appetite are commonespecially when the dosage is increased too quicklywhich can cause people to eat less without recognizing theyre at risk for malnutrition
Although lifestyle interventions (low-calorie diets and exercise) are still the cornerstone of weight management, weight loss achieved through this approach is extremely difficult to sustain in the long term, particularly due to physiological adaptations that reduce the energy expended or increase appetite to compensate for the missing calories
Blitz puts it, If implemented faithfully, this could indeed be just what the doctor ordered for both American patients and American industry. Risks of Compounded GLP-1s Some patients previously relied on compounded semaglutide or tirzepatide during shortages
These are signs that the glucagon component is driving energy expenditure at a level that meaningfully contributes to the overall weight loss beyond what GLP-1 and GIP provide alone
.jpg)
